Wessels JAM - Search Results

1

Pharmacogenetic interaction analysis for the efficacy of systemic treatment in metastatic colorectal cancer.

Pander J, Wessels JAM, Gelderblom H, van der Straaten T, Punt CJA, Guchelaar HJ. Pander J, et al. Among authors: wessels jam. Ann Oncol. 2011 May;22(5):1147-1153. doi: 10.1093/annonc/mdq572. Epub 2010 Nov 3. Ann Oncol. 2011. PMID: 21048041 Free article. Clinical Trial.

2

Pharmacogenetic pathway analysis for determination of sunitinib-induced toxicity.

van Erp NP, Eechoute K, van der Veldt AA, Haanen JB, Reyners AK, Mathijssen RH, Boven E, van der Straaten T, Baak-Pablo RF, Wessels JA, Guchelaar HJ, Gelderblom H. van Erp NP, et al. J Clin Oncol. 2009 Sep 10;27(26):4406-12. doi: 10.1200/JCO.2008.21.7679. Epub 2009 Aug 10. J Clin Oncol. 2009. PMID: 19667267

3

Effect of genetic polymorphisms in genes encoding GST isoenzymes on BU pharmacokinetics in adult patients undergoing hematopoietic SCT.

ten Brink MH, Wessels JA, den Hartigh J, van der Straaten T, von dem Borne PA, Guchelaar HJ, Zwaveling J. ten Brink MH, et al. Bone Marrow Transplant. 2012 Feb;47(2):190-5. doi: 10.1038/bmt.2011.55. Epub 2011 Mar 28. Bone Marrow Transplant. 2012. PMID: 21441958

4

Recent insights in the pharmacological actions of methotrexate in the treatment of rheumatoid arthritis.

Wessels JA, Huizinga TW, Guchelaar HJ. Wessels JA, et al. Rheumatology (Oxford). 2008 Mar;47(3):249-55. doi: 10.1093/rheumatology/kem279. Epub 2007 Nov 28. Rheumatology (Oxford). 2008. PMID: 18045808 Review.

5

Pharmacogenetics in treatment of rheumatoid arthritis.

Kooloos WM, Huizinga TW, Guchelaar HJ, Wessels JA. Kooloos WM, et al. Curr Pharm Des. 2010;16(2):164-75. doi: 10.2174/138161210790112764. Curr Pharm Des. 2010. PMID: 20205662 Review.

6

Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19.

Swen JJ, van der Straaten T, Wessels JA, Bouvy ML, Vlassak EE, Assendelft WJ, Guchelaar HJ. Swen JJ, et al. Eur J Clin Pharmacol. 2012 Apr;68(4):363-70. doi: 10.1007/s00228-011-1130-4. Epub 2011 Oct 8. Eur J Clin Pharmacol. 2012. PMID: 21984116 Free PMC article.

7

CYP2D6 genotype in relation to tamoxifen efficacy in a Dutch cohort of the tamoxifen exemestane adjuvant multinational (TEAM) trial.

Dezentjé VO, van Schaik RH, Vletter-Bogaartz JM, van der Straaten T, Wessels JA, Kranenbarg EM, Berns EM, Seynaeve C, Putter H, van de Velde CJ, Nortier JW, Gelderblom H, Guchelaar HJ. Dezentjé VO, et al. Breast Cancer Res Treat. 2013 Jul;140(2):363-73. doi: 10.1007/s10549-013-2619-6. Epub 2013 Jul 11. Breast Cancer Res Treat. 2013. PMID: 23842856 Clinical Trial.

8

Pharmacogenetics of tomorrow: the 1 + 1 = 3 principle.

Pander J, Wessels JA, Mathijssen RH, Gelderblom H, Guchelaar HJ. Pander J, et al. Pharmacogenomics. 2010 Jul;11(7):1011-7. doi: 10.2217/pgs.10.87. Pharmacogenomics. 2010. PMID: 20602619

9

Polymorphisms in endothelial nitric oxide synthase (eNOS) and vascular endothelial growth factor (VEGF) predict sunitinib-induced hypertension.

Eechoute K, van der Veldt AA, Oosting S, Kappers MH, Wessels JA, Gelderblom H, Guchelaar HJ, Reyners AK, van Herpen CM, Haanen JB, Mathijssen RH, Boven E. Eechoute K, et al. Clin Pharmacol Ther. 2012 Oct;92(4):503-10. doi: 10.1038/clpt.2012.136. Epub 2012 Sep 5. Clin Pharmacol Ther. 2012. PMID: 22948895

10

Criteria for the selection of single nucleotide polymorphisms in pathway pharmacogenetics: TNF inhibitors as a case study.

Kooloos WM, Wessels JA, van der Straaten T, Huizinga TW, Guchelaar HJ. Kooloos WM, et al. Drug Discov Today. 2009 Sep;14(17-18):837-44. doi: 10.1016/j.drudis.2009.05.017. Epub 2009 Jun 12. Drug Discov Today. 2009. PMID: 19524701 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

52 results

Search Page

Filters